UCSF and Biohub Develop New Material for More Consistent Lab-Grown Organs

The Organoid Consistency Problem

Scientists at UCSF and the Chan Zuckerberg Biohub have developed a new material that could solve one of bioprinting's persistent challenges: growing consistent, reproducible organoids in the lab.

Organoids — miniature, simplified versions of organs grown from stem cells — hold enormous promise for drug testing and disease research. But traditional methods struggle with consistency: cells often cluster unpredictably, making results difficult to reproduce.

The Solution: Alginate-Matrigel Composite

The team created an alginate-Matrigel mixture that behaves like "wet sand" — holding printed cell clusters in position while loosening as cells grow.

Standard Matrigel alone proved unsuitable for bioprinting. As lead researcher Dr. Zev Gartner explained: "Liquid Matrigel is too runny to print into, and once it cures, it's too soft to hold a shape. We wanted a material that lets us place cells exactly where we want them but still allows them to grow."

The composite achieves what neither material could do alone: precise placement and proper growth.

Validated Across Multiple Tissue Types

The method was tested across several tissue types:

• Mouse intestinal and salivary gland cells
• Human vascular cells
• Human stem-cell-derived brain cells

Intestinal cells printed in linear configurations formed fluid-carrying tubes resembling human intestinal structures — a significant step toward functional tissue engineering.

Not Building Tissues Like Legos

Gartner emphasized the philosophy behind the approach: "We place cells where they need to be and let their developmental programs assemble the tissue. The goal is to reach a stage where an organ begins to build itself."

This represents a shift from top-down bioprinting toward enabling biological self-assembly — a more promising path toward functional organs.

Implications

The material could accelerate:

• Drug development and toxicity testing
• Disease modeling
• Personalized medicine approaches
• Eventually, replacement tissue manufacturing

While full organs remain years away, this material addresses a critical bottleneck in getting organoid research to reliable, reproducible results.